Quarterly report · Q3
6523.TEDINET S100SW3M
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥256.7bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥89.9bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥356.4bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥265.1bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥94.5bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | −¥5.1bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥9.3bn | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥21.4bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥10.9bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥13.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥10.7bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥179m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥7.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥4.0bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥11.2bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥8.7bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥3.4bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥11.2bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥8.7bn | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥3.6bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥2.2bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥541.0bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥561.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥569.9bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥416.7bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥422.7bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥124.3bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥138.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥138.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥136.1bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥124.7bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥138.0bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥137.9bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥43.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥60.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥59.4bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥95.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥28.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥6.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥17.1bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥17.5bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥11.3bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥31.1bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥40.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥32.9bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-88.7 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-69.07 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-25.84 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥27.33 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥17.69 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-88.7 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-69.07 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-25.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥27.07 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥17.53 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 23.0% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.6% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥7.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥80.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥80.3bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥8.8bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥79.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥79.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥4.9bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥95.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥95.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | −¥11.6bn |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥254.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥254.9bn |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥13.0bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥83.7bn |
| jpcrp040300-q3r_E36976-000Diabetes Managementreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥80.4bn |
| jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥6.3bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥99.2bn |
| jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.5bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥263.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥34.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 875
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity IFRS | CurrentQuarterInstant | 124293000000 | JPY |
| Liabilities and equity IFRS | Prior1YearInstant | 561567000000 | JPY |
| Liabilities and equity IFRS | CurrentQuarterInstant | 540964000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 265102000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 256683000000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 138206000000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 140801000000 | JPY |
| Gross profit IFRS | Prior1YTDDuration | 126895000000 | JPY |
| Gross profit IFRS | CurrentYTDDuration | 115881000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YTDDuration | 105874000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYTDDuration | 112115000000 | JPY |
| Other income IFRS | Prior1YTDDuration | 1414000000 | JPY |
| Other income IFRS | CurrentYTDDuration | 3358000000 | JPY |
| Other expenses IFRS | Prior1YTDDuration | 741000000 | JPY |
| Other expenses IFRS | CurrentYTDDuration | 12072000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | -264000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | -180000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 21429000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | -5128000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 148000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 552000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 14163000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 9202000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 7414000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | -13778000000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 3801000000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | -2619000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 3612000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | -11159000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | 3403000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | -11154000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YTDDuration | 209000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYTDDuration | -4000000 | JPY |
| Basic earnings loss per share IFRS | Prior1YTDDuration | 27.33 | |
| Basic earnings loss per share IFRS | CurrentYTDDuration | -88.70 | |
| Diluted earnings loss per share IFRS | Prior1YTDDuration | 27.07 | |
| Diluted earnings loss per share IFRS | CurrentYTDDuration | -88.70 | |
| Revenue IFRS | Prior1QuarterDuration | 94517000000 | JPY |
| Revenue IFRS | CurrentQuarterDuration | 89864000000 | JPY |
| Cost of sales IFRS | Prior1QuarterDuration | 48626000000 | JPY |
| Cost of sales IFRS | CurrentQuarterDuration | 49072000000 | JPY |
| Gross profit IFRS | Prior1QuarterDuration | 45891000000 | JPY |
| Gross profit IFRS | CurrentQuarterDuration | 40791000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1QuarterDuration | 35057000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentQuarterDuration | 40724000000 | JPY |
| Other income IFRS | Prior1QuarterDuration | 217000000 | JPY |
| Other income IFRS | CurrentQuarterDuration | 369000000 | JPY |
| Other expenses IFRS | Prior1QuarterDuration | 164000000 | JPY |
| Other expenses IFRS | CurrentQuarterDuration | 9704000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1QuarterDuration | 1000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |